Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
InnovAge HoldingINNV +2.45%66 5-Year Yield-on-Cost % is 0.00 as of Aug. 05, 2026. GuruFocus rates INNV with a GF Score™ of 66/100 and a GF Value™ of $6.58 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 275 Healthcare Providers & Services companies, InnovAge Holding ranks worse than 363636% on this metric.
InnovAge Holding's yield on cost for the quarter that ended in Mar. 2026 was 0.00.
The historical rank and industry rank for InnovAge Holding's 5-Year Yield-on-Cost % or its related term are showing as below:
INNV's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.86 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
InnovAge Holding 5-Year Yield-on-Cost % Related Terms
INNV vs HCSG, ARDT, AGL: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, InnovAge Holding's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InnovAge Holding 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, InnovAge Holding's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where InnovAge Holding's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
InnovAge Holding (INNV) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 05, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on InnovAge Holding and its competitors. According to the industry distribution chart, InnovAge Holding ranks #999999 out of 275 companies in the Healthcare Providers & Services industry.
Is InnovAge Holding's 5-Year Yield-on-Cost % too high?
InnovAge Holding's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, InnovAge Holding ranks #999999 out of 275 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, InnovAge Holding has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does InnovAge Holding's 5-Year Yield-on-Cost % compare to HCSG and ARDT?
According to the Healthcare Providers & Services industry distribution chart, InnovAge Holding ranks #999999 out of 275 companies for 5-Year Yield-on-Cost %. This places InnovAge Holding in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.86, based on 275 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on InnovAge Holding and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InnovAge Holding's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InnovAge Holding stock overvalued right now?
Based on GuruFocus' analysis, InnovAge Holding (INNV) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.58, compared to a current price of $11.10 — trading 68.6% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. InnovAge Holding's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For InnovAge Holding (INNV), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InnovAge Holding (INNV) Overvalued in 2026?
Based on GuruFocus' analysis, InnovAge Holding stock appears to be overvalued.
The current stock price of $11.10 is trading 68.6% above its estimated GF Value™ of $6.58.
GuruFocus considers InnovAge Holding to be Significantly Overvalued.
Key valuation signals for INNV:
5-Year Yield-on-Cost %: 0.00
GF Value™: $6.58 vs. price of $11.10 (68.6% above fair value)
No single metric tells the full story. See the INNV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.
66GF Score
Get the complete analysis for INNV
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INNV has been successfully added to your 
